Immortalized Baby Mouse Kidney Epithelial Cells (iBMK)
|T0082||1x106 cells / 1.0 ml|
The Immortalized Baby Mouse Kidney Epithelial Cells (iBMK, Clone W2) is derived by co-expression of adenovirus E1A and dominant-negative p53 (p53DD). In addition to its non-tumorigenicity, this cell line maintains its primary phenotype and expresses epithelial-specific markers such as E-cadherin, cytokeratin 8 and 18. Together with Bax Knockdown iBMK (T3024), Bak Knockdown iBMK (T3025) and Bax/Bak Double Knockdown iBMK (T3026), these cell lines form the ideal system for studying mechanisms regulating apoptosis. In the same way, when paired with Atg5 Knockdown iBMK (T3027) and Atg7 Knockdown iBMK (T3028), they present an attractive model for investigating the relationship between autophagy and metabolism homeostasis.
|Species||Mouse (M. musculus)|
|Species description||5-day-old wild-type baby C57B/6 mouse|
|Seeding Density||Thaw entire contents into an appropriate T25 flask as specified in the Propagation instructions.|
|Immortalization Method||Serial passaging and electroporation transfection with linearized DNA of E1A and p53DD|
For Research Use Only
|Unit quantity||1x106 cells / 1.0 ml|
|Cell Type||Immortalized Cells|
E-cadherin, CK8 and CK18
Use of PriCoatTMT25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) is required for cell adhesion to the culture vessels. Grow cells inECM-coated culture vessels unless otherwise specified in the Propagation Requirements below.
The base medium for this cell line is Prigrow III medium available at abm, Cat. No. TM003. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (TM999)* to a final concentration of 10% and Penicillin/Streptomycin Solution (G255) to a final concentration of 1%.
1. Western blot was used to confirm the presence of E1A and p53DD gene in the immortalized cell line. 2. Western blot was used to check epithelial markers E-cadherin and cytokeratin expression.
1. For for-profit organizations and corporations, please contact [email protected] for pricing of this item.
2. Sale of this item is subjected to the completion of a Material Transfer Agreement (MTA) by the purchasing individual/institution for each order. If you have any questions regarding this, please contact us at [email protected].
3. All test parameters provided in the CoA are conducted using abm's standardized culture system and procedures. The stated values may vary under the end-user's culture conditions. Please verify that the product is suitable for your studies by referencing published papers or ordering RNA (0.5 μg, Cat.# C207, $450.00) or cell lysate (100 μg, Cat.# C206, $600.00) to perform preliminary experiments, or alternatively use our Gene Expression Assay Service (Cat# C138). All sales are final.
4. We recommend live cell shipments for ease of cell transfer and this option can be requested at the time of ordering. Please note that the end-user will need to evaluate the feasibility of live cell shipment by taking into account the final destination's temperature variation and its geographical location. In addition, we thoroughly test our cell lines for freeze-thaw recovery. If frozen cells were received and not recovered in your lab under the exact, specified conditions (using recommended culture vessel, media, additional supplements, and atmospheric conditions), a live cell replacement is possible at a cost (plus shipping).
5. All of abm's cell biology products are for research use ONLY and NOT for therapeutic/diagnostic applications. abm is not liable for any repercussions arising from the use of its cell biology product(s) in therapeutic/diagnostic application(s). Please contact a technical service representative for more information.
6. abm makes no warranties or representations as to the accuracy of the information on this site. Citations from literature and provided for informational purposes only. abm does not warrant that such information has been shown to be accurate.
7. abm warrants that cell lines shall be viable upon initiation of culture for a period of thirty (30) days after shipment and that they shall meet the specifications on the applicable abm Material Product Information sheet, certificate of analysis, and/or catalog description. Such thirty (30) day period is referred to herein as the "Warranty Period."
- Important Considerations for Immortalized Cells
- Immortalized Cell Handling Instructions Upon Arrival
- Subculturing Protocol
- Freezing Protocol
- Hepatocyte Instructions
- Thawing Protocol
- Immortalized Cell Lines Flyer #1
- Cell Line Catalog (Volume 2)
- Immortalized Cell Lines Flyer #2
- Immortalized Cells FAQ
|I want to make sure these cells express my gene of interest before I decide to buy the cell line. Can you provide a sample so this can be tested?|
We do not carry out downstream characterization or gene expression profiling of our cell lines. To facilitate your preliminary experiments we can provide an RNA extraction (0.5ug total RNA) or cell lysate (100ug/100ul provided in 62.5mM Tris‐HCl, 2% SDS, 10% Glycerol, 50mM DTT, 0.01% w/v Bromophenol Blue) for any of our immortalized cell lines for a small fee. Please inquire directly for more information. The lead time will be around 2 weeks from the time of placing an order (if the item is in stock).
|How often do I need to change the media?|
The media should be changed every 2-3 days.
|Why do these cells need bio safety level II?|
In order to be more cautious, we follow the CDC-NIH recommendations that all mammalian sourced products should be handled at the Biological Safety Level 2 to minimize exposure of potentially infectious products. This information can be found in 'Biosafety in Microbiological and Biomedical Laboratories' (1999). Your institution's Safety Officer or Technical Services will be able to make the call as to whether BioSafety Level I is possible with these cells at your site if required.
|Do you sell ECM coated T75 flasks?|
Yes we can provide a coating service. Please inquire with [email protected]
|Is it necessary that we have to use the recommended T25 ECM-coated flasks for growing the cells? Can we use normal ECM coated 60mm/90mm petri plates for growing the cells?|
We strongly recommend using G299 T25 flasks to ensure recovery of these cells before testing other plates.
|What can I coat a larger dish to subculture?|
We also offer applied extracellular matrix (collagen type I) in liquid form, for the coating of larger flasks and other required plasticware: http://www.abmgood.com/Applied-Cell-Extracellular-Matrix-G422.html
|How long can I store frozen vials for?|
Cells that are properly frozen using an effective cryoprotective agent can be stored in liquid nitrogen indefinitely without affecting their recovery.
|When are cells plated for live cell shipments?|
1 day prior to shipping
|Should the cap of the flask be changed before starting the cell culturing step?|
No, there is no need in sterile biosafety cabinets unless it has contacted any non-sterile condition (e.g. touching the contaminated tip, etc.).
|What is the recommended storage temperature?|
In general, if you received: Live cells: acclimatize for 3-4 hrs at at the recommended conditions stated for the cell line under the propagation section, and then change media afterwards. Frozen cells: Immediately place cells in liquid nitrogen; -180C.
|How is cell density crucial for drug selection?|
If antibiotic selection is applicable to the target cells, we suggest getting rid of all the background cells so that the cell density is kept lower (even 20-30%). However, once the clones are selected by clonal dilution, we don't need the drug to still be present. If needed, the cell density should be towards the higher end since cells are already selected. Any primary cells still present will be depleted as a result of senescence and the cell population that remains will be resistant to the specific antibiotic.
|My cells are not detaching, what method do you recommend to trypsinize the cells?|
1. Incubate the coated plate containing trypsin solution at recommended temperature indicated in the propagation section for 3-5 min till the cells round up, monitoring from time to time under microscope. 2. Diluting G422 (1:1) with PBS and coating for lesser time. Sometimes the collagen content in G422 is higher and thus make stronger bonding with cells. 3. You can try reducing the incubation time as well for coating the plate to make a thinner layer.
|Why is it important to determine the optimal seeding density?|
The seeding density we recommend is for when cells are plated to a new vessel. The optimal seeding density should allow cells to attach to the surface and have room to proliferate. If you seed too little, cells may not attach well to the surface (for adherent cells). Seeding density is important as many cells (adherent or suspension cells) need to be in close proximity for better growth. Cell-cell interactions allow cells to communicate with each other in response to changes in their microenvironment. This ability to send and receive signals is essential for the survival of the cell. In other cases, if the seeding density is too low, cells may attach but a retardation in cell growth is observed. If you seed too high, the cells will attach but there is insufficient room for further proliferation and they will stop replicating.
- Degenhardt, K et al. "BAX and BAK mediate p53-independent suppression of tumorigenesis" Cancer Cell 2(3):193-203 (2002). PubMed: 12242152.
- Zheng, JY et al. "Alterations in the characteristic size distributions of subcellular scatterers at the onset of apoptosis: effect of Bcl-xL and Bax/Bak" J. Biomed. Opt. 15(4):045002 (2010). DOI: 10.1117/1.3462933 20799797.
- Mathew, R et al. "Autophagy suppresses tumor progression by limiting chromosomal instability" Gene Dev. 21(11):1367-1381 (2007). DOI: 10.1101/gad.1545107 . PubMed: PMC1877749.
- Valero, JG et al. "µ-Calpain Conversion of Antiapoptotic Bfl-1 (BCL2A1) into a Prodeath Factor Reveals Two Distinct alpha-Helices Inducing Mitochondria-Mediated Apoptosis " PLoS One 7(6):e38620 (2012). PubMed: PMC3379997.
- Leshchiner, ES et al. "Direct activation of full-length proapoptotic BAK" Proc Natl Acad Sci U S A. 110(11):E986–E995 (2013). DOI: 10.1073/pnas.1214313110. PubMed: PMC3600461.
- Simmons, MJ et al. "Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist" Oncogene 27(10):1421-1428 (2008). DOI: 10.1038/sj.onc.1210771. PubMed: PMC2880719.
- Mathew, R et al. "Autophagy suppresses tumorigenesis through elimination of p62" Cell 137(6):1062-1075 (2009). DOI: 10.1016/j.cell.2009.03.048. PubMed: PMC2802318.
- Mathew, R et al. "Immortalized mouse epithelial cell models to study the role of apoptosis in cancer" Methods in Enzymology 446:77-106 (2008). DOI: 10.1016/S0076-6879(08)01605-4.
- Degenhardt, K et al. "Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis" Cancer Cell 10(1):51-64 (2006). PubMed: 16843265.
- Ewings, KE et al. "ERK1/2-dependent phosphorylation of BIMEL promotes its rapid dissociation from Mcl-1 and Bcl-xL" EMBO J. 26(12):2856-2867 (2007). DOI: 10.1038/sj.emboj.7601723. PubMed: PMC1894764.
- Tan, T et al. "Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy" Cancer Cell 7(3):227-238 (2005). DOI: 10.1016/j.ccr.2005.02.008.
- Kamphorst, JJ et al. "Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids" Proc Natl Acad Sci U S A 110(22):8882-8887 (2013). DOI: 10.1073/pnas.1307237110 . PubMed: PMC3670379.
- Mathew, R et al. "Assessing metabolic stress and autophagy status in epithelial tumors" Methods in Enzymology 453:53-81 (2009). DOI: 10.1016/S0076-6879(08)04004-4 . PubMed: PMC2857509.
- Zheng, J et al. "The c-terminal transmembrane domain of Bcl-xL mediates changes in mitochondrial morphology" Biophys J 94(1):286-297 (2008). DOI: 10.1529/biophysj.107.104323 . PubMed: PMC2134878 .
- Fan, J et al. "Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia" Mol Syst Biol. 9:712 (2013). DOI: 10.1038/msb.2013.65 . PubMed: PMC3882799 .
- Guo, JY et al. "Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis" Genes Dev. 25(5):460-470 (2011). DOI: 10.1101/gad.2016311 . PubMed: PMC3049287.
- Kamphorst, JJ et al. "Liquid chromatography-high resolution mass spectrometry analysis of fatty acid metabolism" Anal Chem 83(23):9114-9122 (2011). DOI: 10.1021/ac202220b . PubMed: PMC3230881.
- Pasternack, RM et al. "Measurement of subcellular texture by optical Gabor-like filtering with a digital micromirror device" Opt Lett. 33(19):2209-2211 (2008). PubMed: PMC2859170.
- Shimazu, T et al. "NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition" Genes Dev. 21(8):929-941 (2007). DOI: 10.1101/gad.1522007. PubMed: PMC1847711.
- Martino, JJ et al. "Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells" Oncogene 32(37):4366-4376 (2012). DOI: 10.1038/onc.2012.471. PubMed: PMC3910169.
- Sulzmaier, FJ et al. "PEA-15 potentiates H-Ras mediated epithelial cell transformation through phospholipase D" Oncogene 31(30):3547-3560 (2012). DOI: 10.1038/onc.2011.514. PubMed: PMC3295902.
- Xie, X et al. "Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma" PLoS One 8(1):e55096 (2013). DOI: 10.1371/journal.pone.0055096. PubMed: PMC3559441.
- Lau, A et al. "A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between keap1 and p62" Mol Cell Biol 30(13):3275-3285 (2010). DOI: 10.1128/MCB.00248-10. PubMed: PMC2897585.
- Kenific, C et al. "NBR1 enables autophagy-dependent focal adhesion turnover" The Journal of Cell Biology 212.5:577-590 (2016). DOI: 10.1083/jcb.201503075. Application: Cell culture.
- Oshimo, Y., Munetomo, A., Magata, F., Suetomi, Y., Sonoda, S., Takeuchi, Y., Tsukamura, H., Ohkura, S., & Matsuda, F. (2021). Estrogen increases KISS1 expression in newly generated immortalized KISS1-expressing cell line derived from goat preoptic area. The Journal of reproduction and development, 67(1), 15–23. https://doi.org/10.1262/jrd.2020-053